Reagent Kit for Qualitative ELISA Detection of IgG Antibodies to SARS-CoV-2 in Human Serum and Plasma "SARS-CoV-2 ELISA-IgG", Series E007

This reagent kit is intended for the qualitative immunoenzymatic (ELISA) detection of IgG antibodies to SARS-CoV-2 in human serum and plasma.

Kit Components

Twelve 8-well strips in a frame with immobilized recombinant antigens on the inner surface of the wells, labeled "SARS-CoV-2 Recombinant Antigen Strips" – 1 package
Negative control sample, aqueous saline solution without SARS-CoV-2 antibodies, labeled "Negative Control Sample" – 1 vial, 1.8 ml
Positive control sample, aqueous saline solution containing SARS-CoV-2 antibodies, labeled "Positive Control Sample" – 1 vial, 2.3 ml
Analytical aqueous saline solution, labeled "Buffer A" – 1 vial, 15 ml
Conjugate of monoclonal anti-human IgG antibodies with horseradish peroxidase, labeled "Conjugate E" – 1 vial, 14 ml
Concentrated wash solution for wells, labeled "Buffer H (20X)" – 1 vial, 50 ml
Tetramethylbenzidine (TMB) solution, labeled "TMB Solution" – 1 vial, 14 ml
Stop reagent, 3.59% hydrochloric acid solution, labeled "Stop Reagent" – 1 vial, 50 ml
Disposable tips – 16 pcs
Disposable wells/trays – 2 pcs
Polyethylene sealing bag (for packaging strips) – 1 pc

Documentation

User manual
Certificate of quality

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Reagent Kit for Qualitative ELISA Detection of IgG Antibodies to SARS-CoV-2 in Human Serum and Plasma "SARS-CoV-2 ELISA-IgG", Series E007, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.

Back